These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8097411)

  • 1. Pharmacology of gastric acid inhibition.
    Shamburek RD; Schubert ML
    Baillieres Clin Gastroenterol; 1993 Mar; 7(1):23-54. PubMed ID: 8097411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of acid secretion.
    Schubert ML; Shamburek RD
    Gastroenterol Clin North Am; 1990 Mar; 19(1):1-25. PubMed ID: 1691738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological aspects of acid secretion.
    Hirschowitz BI; Keeling D; Lewin M; Okabe S; Parsons M; Sewing K; Wallmark B; Sachs G
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):3S-23S. PubMed ID: 7859583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological basis of omeprazole therapy.
    Sachs G; Wallmark B
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuing development of acid pump inhibitors: site of action of pantoprazole.
    Shin JM; Besancon M; Prinz C; Simon A; Sachs G
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: antisecretory drugs: cellular mechanisms of action.
    Soll AH
    Aliment Pharmacol Ther; 1987 Apr; 1(2):77-89. PubMed ID: 2979219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
    Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stomach divalent ion-sensing receptor scar is a modulator of gastric acid secretion.
    Geibel JP; Wagner CA; Caroppo R; Qureshi I; Gloeckner J; Manuelidis L; Kirchhoff P; Radebold K
    J Biol Chem; 2001 Oct; 276(43):39549-52. PubMed ID: 11507103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid secretion and suppression.
    Katz J
    Med Clin North Am; 1991 Jul; 75(4):877-87. PubMed ID: 2072793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R; Ding XQ; Norlén P; Lindström E
    Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gastric acid secretion at the cellular level.
    Wollin A
    Clin Invest Med; 1987 May; 10(3):209-14. PubMed ID: 2887322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors.
    Kromer W; Baron E; Boer R; Eltze M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):7-13. PubMed ID: 2030745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid secretion and the H,K ATPase of stomach.
    Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
    Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17).
    Zimmerhackl B; Wünsch E; Classen M; Schusdziarra V; Schepp W
    Regul Pept; 1993 Jul; 46(3):583-92. PubMed ID: 8105512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The continuing development of gastric acid pump inhibitors.
    Sachs G; Shin JM; Besancon M; Prinz C
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():4-12, discussion 29-31. PubMed ID: 8387826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of acetylcholine-induced secretion of gastric bombesin-like immunoreactivity by cholinergic and histamine H2-receptors, somatostatin and intragastric pH.
    Schusdziarra V; Bender H; Pfeffer A; Pfeiffer EF
    Regul Pept; 1984 Apr; 8(3):189-98. PubMed ID: 6146996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.